UNICA IRIS Institutional Research Information System

MACCIO', ANTONIO PIETRO MARIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 123.747
NA - Nord America 9.426
AS - Asia 1.416
AF - Africa 20
SA - Sud America 18
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 4
Totale 134.640
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 121.069
US - Stati Uniti d'America 9.377
UA - Ucraina 909
CN - Cina 877
SE - Svezia 681
DE - Germania 352
SG - Singapore 292
GB - Regno Unito 258
FI - Finlandia 221
FR - Francia 85
VN - Vietnam 69
KR - Corea 60
IN - India 58
CA - Canada 46
RU - Federazione Russa 34
NL - Olanda 29
IE - Irlanda 22
IR - Iran 13
BE - Belgio 12
ES - Italia 12
AT - Austria 11
EU - Europa 9
HK - Hong Kong 9
TH - Thailandia 8
BR - Brasile 7
CZ - Repubblica Ceca 7
RO - Romania 7
BG - Bulgaria 6
CH - Svizzera 6
AR - Argentina 5
DZ - Algeria 5
TR - Turchia 5
DK - Danimarca 4
EE - Estonia 4
EG - Egitto 4
ID - Indonesia 4
JP - Giappone 4
LT - Lituania 4
PH - Filippine 4
AU - Australia 3
GR - Grecia 3
HU - Ungheria 3
MU - Mauritius 3
PL - Polonia 3
BO - Bolivia 2
CI - Costa d'Avorio 2
CL - Cile 2
CM - Camerun 2
HR - Croazia 2
MG - Madagascar 2
MX - Messico 2
NP - Nepal 2
PK - Pakistan 2
PT - Portogallo 2
SA - Arabia Saudita 2
SC - Seychelles 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BZ - Belize 1
EC - Ecuador 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
TM - Turkmenistan 1
TW - Taiwan 1
Totale 134.640
Salva come PNG Salva come JPEG
Città #
Cagliari 117.169
Uta 3.344
Fairfield 1.282
Woodbridge 1.097
Houston 749
Chandler 624
Boardman 590
Ashburn 580
Nyköping 545
Ann Arbor 534
Seattle 532
Jacksonville 517
Wilmington 504
Cambridge 419
Dearborn 224
New York 169
Nanjing 165
Singapore 159
Boston 144
Beijing 123
Santa Clara 122
San Diego 89
Helsinki 86
Shanghai 77
Dong Ket 68
Guangzhou 62
Menlo Park 57
Milan 56
Shenyang 49
London 46
Redwood City 43
Seoul 42
Nanchang 41
Changsha 38
Hebei 32
Rome 32
Toronto 32
Jiaxing 31
Los Angeles 29
Pune 29
Norwalk 28
Jinan 27
Tianjin 27
Verona 27
Mountain View 22
Orange 22
Zhengzhou 19
Auburn Hills 16
Sassari 14
Hangzhou 13
Phoenix 13
Brussels 12
Ningbo 12
Wuhan 12
Vienna 11
Kunming 10
Hefei 9
Saint Petersburg 9
Atlanta 8
Nuremberg 8
San Francisco 8
Bangkok 7
Chicago 7
Dublin 7
Taizhou 7
Washington 7
Amsterdam 6
Kilburn 6
Munich 6
Barcelona 5
Brandizzo 5
Falls Church 5
Hong Kong 5
Islington 5
Rockville 5
Augusta 4
Berlin 4
Chiswick 4
Fuzhou 4
Hounslow 4
Philadelphia 4
Redmond 4
San Mateo 4
Sofia 4
Somma Vesuviana 4
Tonara 4
Torino 4
Trieste 4
Assago 3
Athens 3
Copenhagen 3
Council Bluffs 3
Courtice 3
Den Haag 3
Detroit 3
Florence 3
Frankfurt am Main 3
Gunpo 3
Jakarta 3
Lanzhou 3
Totale 131.029
Salva come PNG Salva come JPEG
Nome #
Krill Oil supplementation modifies endocannabinoid congeners profile in cachectic advanced cancer patients 3.231
Pathogenesis and Treatment Options of Cancer Related Anemia: Perspective for a Targeted Mechanism-Based Approach 2.426
Feasibility and safety of total laparoscopic hysterectomy for huge uteri without the use of uterine manipulator: description of emblematic cases 2.377
Randomized phase III clinical trial of a combined treatment with carnitine plus celecoxib +/- megestrol acetate for patients with cancer-related anorexia/cachexia syndrome 2.340
Abdominal leiomyosarcomatosis after surgery with external morcellation for occult smooth muscle tumors of uncertain malignant potential: A case report 2.180
The cachexia score (CASCO) as a tool for staging cachectic cancer patients 2.116
Selenium is effective in inducing lymphocyte progression through cell cycle in cancer patients: potential mechanisms for its activity 2.113
Muscle wasting as main evidence of energy impairment in cancer cachexia: future therapeutic approaches 1.983
Microenvironmental M1 tumor-associated macrophage polarization influences cancer-related anemia in advanced ovarian cancer: Key role of interleukin-6 1.943
A PET-positive rapidly growing mass of the abdominal wall after cesarean section with an unexpected diagnosis of vernix caseosa granuloma: a case report 1.885
Advances in pharmacologic strategies for cancer cachexia 1.824
Combined laparoscopic excisional surgery for synchronous endometrial and rectal adenocarcinoma in an obese woman 1.802
Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia 1.792
Laparoscopic removal of a very large uterus weighting 5320 g is feasible and safe: a case report. 1.731
Krill oil to improve blood lipids status in advanced cancer patient with cachexia 1.711
Open phase II study on efficacy and safety of an oral amino acid functional cluster supplementation in cancer cachexia 1.701
Next generation sequencing driven successful combined treatment with laparoscopic surgery and immunotherapy for relapsed stage IVB cervical and synchronous stage IV lung cancer 1.694
Long-Term Survival in a Patient With Abdominal Sarcomatosis From Uterine Leiomyosarcoma: Role of Repeated Laparoscopic Surgery in Treatment and Follow-Up 1.671
Successful laparoscopic management of a giant ovarian cyst 1.669
Efficacy and safety of a two drug-combination regimen for cancer-related cachexia in the clinical practice. 1.664
The role of inflammation, iron, and nutritional status in cancer-related anemia: results of a large, prospective, observational study 1.655
Future prospects for PD-1 targeting, macrophage infiltration, and IDO pathway activation in patients with sarcomas 1.652
Phase II nonrandomized study of the efficacy and safety of COX-2 inhibitor celecoxib on patients with cancer cachexia 1.644
A multitargeted treatment approach for anemia and cachexia in metastatic castration-resistant prostate cancer 1.619
Randomized phase III clinical trial of five different arms of treatment for patients with cancer cachexia: interim results 1.618
Efficacy of l-carnitine administration on fatigue, nutritional status, oxidative stress, and related quality of life in 12 advanced cancer patients undergoing anticancer therapy 1.604
Large twisted ovarian fibroma associated with Meigs' syndrome, abdominal pain and severe anemia treated by laparoscopic surgery 1.519
Surgical outcome and complications of total laparoscopic hysterectomy for very large myomatous uteri in relation to uterine weight: a prospective study in a continuous series of 461 procedures 1.518
Surprising results of a supportive integrated therapy in myelofibrosis 1.510
Defibrotide in the COVID-19 coagulopathy: what is the timing? 1.503
Laparoscopic hysterectomy as optimal approach for 5400 grams uterus with associated polycythemia: A case report 1.484
L-Carnitine: An adequate supplement for a multi-targeted anti-wasting therapy in cancer 1.476
Multifactorial pathogenesis of COVID-19-related coagulopathy. Can defibrotide have a role in the early phases of coagulation disorders? 1.407
An interdisciplinary approach for laparoscopic removal of a large retroperitoneal pelvic schwannoma attached to vital vessels: A case report 1.383
Feasibility and safety of total laparoscopic hysterectomy for uteri weighing from 1.5 kg to 11.000 kg 1.333
Editorial: Biological Mechanism-Based and Patient-Centered Management of Cancer-Related Symptoms and Syndromes 1.316
EFFICACY AND SAFETY OF A TWO DRUG-COMBINATION REGIMEN FOR CANCER-RELATED CACHEXIA IN THE CLINICAL PRACTICE 1.239
(0) Save to: more options IMPROVEMENT OF PHYSICAL ACTIVITY AS AN ALTERNATIVE OBJECTIVE VARIABLE TO MEASURE TREATMENT EFFECTS OF ANTI CACHEXIA THERAPY IN CANCER PATIENTS 1.162
Role of interleukin-2 (IL-2) in cancer-related immune deficiency: in vitro response to IL-2, production of IL-2, and IL-2 receptor expression in patients with advanced cancer 1.096
Quantitative evaluation of oxidative stress, chronic inflammatory indices and leptin in cancer patients: correlation with stage and performance status 1.086
null 998
Quantitative evaluation of oxidative stress, chronic inflammatory indexes, and leptin in cancer patients: Correlation with stage and performance status. 977
New perspective on the nutritional approach to cancer-related anorexia/cachexia: Preliminary results of a randomised phase III clinical trial with five different arms of treatment 946
Peripheral blood lymphocyte response to recombinant and non-recombinant interleukin 2 in previously treated patients with Hodgkin's disease, long-time off-therapy 923
Interleukin 2 (IL 2) and cancer. In vitro response to exogenous R and non-R IL 2 by PHA-activated and non-PHA-activated PBMC from patients with cancer 890
Blocking inflammation to improve immunotherapy of advanced cancer 884
Role of M1-polarized tumor-associated macrophages in the prognosis of advanced ovarian cancer patients 845
Interleukin 2 (IL 2) relationships with the cancer-related immunodeficiency: in vitro response to exogenous IL 2 by PHA-activated and non PHA-activated peripheral blood mononuclear cells from cancer patients 830
null 819
The role of interleukin-6 in the evolution of ovarian cancer: clinical and prognostic implications - a review 819
Laparoscopic management of a giant mucinous benign ovarian mass weighing 10150 grams: A case report 819
Ovarian hyperstimulation in premenopausal women during adjuvant tamoxifen treatment for endocrine-dependent breast cancer: A report of two cases 819
Cisplatin : an old drug with a newfound efficacy -- from mechanisms of action to cytotoxicity 816
Role of inflammation and oxidative stress in post-menopausal oestrogen-dependent breast cancer 783
Antioxidant agents are effective in inducing lymphocyte progression through cell cycle in advanced cancer patients: assessment of the most important laboratory indexes of cachexia and oxidative stress 771
Three cases of laparoscopic myomectomy performed during pregnancy for pedunculated uterine myomas 770
Successful pregnancy following myomectomy of a giant uterine myoma: role of a combined surgical approach 757
Subcutaneous interleukin-2 in combination with medroxyprogesterone acetate and antioxidants in advanced cancer responders to previous chemotherapy: phase II study evaluating clinical, quality of life, and laboratory parameters 740
Prevention of nausea and vomiting (N&V) in cancer patients receiving high-dose cisplatin. Assessment of the potential antiemetic activity of transdermal fentanyl (TTS-F) compared to standard antiemetic treatment in acute and delayed N&V: first clinical report 733
A PHASE II STUDY WITH ANTIOXIDANTS, BOTH IN THE DIET AND SUPPLEMENTED, PHARMACO-NUTRITIONAL SUPPORT,PROGESTAGEN AND ANTI-COX-2 SHOWING EFFICACY AND SAFETY IN PATIENTS WITH CANCER-RELATED ANOREXIA-CACHEXIA AND OXIDATIVE STRESS 723
Cancer-related anorexia/cachexia syndrome and oxidative stress: an innovative approach beyond current treatment 721
A phase II study with antioxidants, both in the diet and supplemented, pharmaconutritional support, progestagen, and anti-cyclooxygenase-2 showing efficacy and safety in patients with cancer-related anorexia/cachexia and oxidative stress 719
Immunotherapy (recombinant interleukin 2), hormone therapy (medroxyprogesterone acetate) and antioxidant agents as combined maintenance treatment of responders to previous chemotherapy 710
null 709
Reactive oxygen species, antioxidant mechanisms and serum cytokine levels in cancer patients: impact of an antioxidant treatment 708
Dose-intense phase II study of weekly cisplatin and epidoxorubicin plus medroxyprogesterone acetate and recombinant interleukin 2 in stage IIIB-IV non-small cell lung cancer 687
Antioxidant agents alpha lipoic acid, N-Acetyl cysteine and MESNA (2-mercaptoethane sulfonate) are effective in inducing lymphocyte progression through cell cycle in advanced cancer patients 677
Experimental drugs for chemotherapy-and cancer-related anemia 652
Improvement of physical activity as an alternative objective variable to measure treatment effects of anticachexia therapy in cancer patients 631
Laparoscopic splenectomy both for primary cytoreductive surgery for advanced ovarian cancer and for secondary surgery for isolated spleen recurrence: feasibility and technique 625
Next-Generation Sequencing Whole-Genome Analysis for Targeted Treatment Approach of Metastatic Bartholin Gland Adenocarcinoma: An Emblematic Case Report and Review of the Literature 616
Novel technique of extracorporeal intrauterine morcellation after total laparoscopic hysterectomy: Three emblematic case reports 603
Effect of Cancer-Related Cachexia and Associated Changes in Nutritional Status, Inflammatory Status, and Muscle Mass on Immunotherapy Efficacy and Survival in Patients with Advanced Non-Small Cell Lung Cancer 583
Randomised Phase III Clinical Trial of a Combined Treatment With Carnitine plus Celecoxib +/- Megestrol Acetate for Patients With Cancer-related Anorexia/cachexia Syndrome 583
Managing cancer-related anorexia/cachexia 582
Serum levels of leptin and proinflammatory cytokines in patients with advanced-stage cancer at different sites 579
Phase II study of subcutaneously administered interleukin-2 in combination with medroxyprogesterone acetate and antioxidant agents as maintenance treatment in advanced cancer responders to previous chemotherapy 576
Induction chemotherapy followed by concomitant chemoradiation therapy in advanced head and neck cancer: a phase II study for organ-sparing purposes evaluating feasibility, effectiveness and toxicity 568
Cancer-related cachexia and oxidative stress: beyond current therapeutic options 563
The mechanism of cancer cell death by PARP inhibitors goes beyond DNA damage alone 548
Laparoscopic management of isolated nodal recurrence in gynecological malignancies is safe and feasible even for large metastatic nodes up to 8 cm: A prospective case series 540
Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: An evaluation of effectiveness, safety and costs 539
The impact of different antioxidant agents alone or in combination on reactive oxygen species, antioxidant enzymes and cytokines in a series of advanced cancer patients at different sites: correlation with disease progression 530
Multitargeted treatment of cancer cachexia 528
Serum values of proinflammatory cytokines are inversely correlated with serum leptin levels in patients with advanced stage cancer at different sites 516
Cachexia and oxidative stress in cancer: an innovative therapeutic management 515
A phase II study with antioxidants, pharmaco-nutritional support, progestagen and anti-COX-2 showing efficacy and safety in patients with cancer-related anorexia/cachexia (CACS) and oxidative stress (OS) 512
Clinical and immunological evaluation of schizophyllan (SPG) in combination with standard chemotherapy in patients with head and neck squamous cell carcinoma 509
Quantitative evaluation of oxidative stress, chronic inflammatory indices and leptin in cancer patients: correlation with stage and performance status 505
Decrease in neutrophil-to-lymphocyte ratio during neoadjuvant chemotherapy as a predictive and prognostic marker in advanced ovarian cancer 505
Randomised phase III clinical trial of 5 different arms of treatment for patients with cancer-related anorexia/cachexia syndrome (CACS): Interim results 504
Serum levels of leptin and proinflammatory cytokines in patients with advanced stage cancer at different sites 502
Functional and surface phenotype study of lymphocyte subsets in peripheral blood and lymph nodes of breast cancer patients 491
Management of anemia of inflammation in the elderly 491
Prognostic Role of Cell Blood Count in Chronic Myeloid Neoplasm and Acute Myeloid Leukemia and Its Possible Implications in Hematopoietic Stem Cell Transplantation 490
Six-week induction chemotherapy followed by concomitant chemoradiation therapy in stage IV head and neck cancer: a phase II study with organ-sparing purposes 487
Current pharmacotherapy options for cancer anorexia and cachexia 486
A randomized phase III clinical trial of a combined treatment for cachexia in patients with gynecological cancers: Evaluating the impact on metabolic and inflammatory profiles and quality of life 486
Cytokine activity in cancer-related anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate 484
Correlation of Leptin, Proinflammatory Cytokines and Oxidative Stress with Tumor Size and Disease Stage of Endometrioid (Type I) Endometrial Cancer and Review of the Underlying Mechanisms 482
Totale 108.081
Salva come PNG Salva come JPEG
Categoria #
all - tutte 189.680
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 189.680
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206.286 0 0 0 0 0 0 2.677 823 562 446 493 1.285
2020/202131.686 1.045 1.043 1.398 6.771 6.467 4.501 3.242 2.424 776 1.621 1.487 911
2021/20227.047 551 514 450 439 724 447 469 481 607 538 702 1.125
2022/202313.231 1.055 1.398 1.181 1.004 925 1.439 748 1.437 967 980 1.354 743
2023/202415.847 999 643 533 1.065 1.529 2.830 2.205 1.006 757 1.074 1.672 1.534
2024/202516.796 2.466 3.754 3.110 3.246 1.642 2.426 152 0 0 0 0 0
Totale 135.122